Cord Blood Therapies
CLEVECORD (HPC Cord Blood)
CLEVELAND CORD BLOOD CENTER
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

HPC Cord Blood
BLOODWORKS
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

HPC Cord Blood
MD ANDERSON CORD BLOOD BANK
Approved by the U.S. FDA in June 2018 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

Hemacord (HPC Cord Blood)
NEW YORK BLOOD CENTER
Approved by the U.S. FDA in 2011 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

Allocord (HPC Cord Blood)
SSM CARDINAL GLENNON CHILDREN’S MEDICAL CENTER
Approved by the U.S. FDA in 2013 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

Ducord (HPC Cord Blood)
DUKE UNIVERSITY MEDICAL CENTER
Approved by the U.S. FDA in 2012 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

HPC Cord Blood
CLINIMMUNE
Approved by the U.S. FDA in 2012 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

HPC Cord Blood
LIFE SOUTH
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

Categories: Stem Cells therapy

NBScience

contract research organization

stem cell therapy